Article Text

Download PDFPDF
Endothelial dysfunction in young patients with rheumatoid arthritis and low disease activity
  1. G Vaudo1,
  2. S Marchesi1,
  3. R Gerli2,
  4. R Allegrucci2,
  5. A Giordano2,
  6. D Siepi1,
  7. M Pirro1,
  8. Y Shoenfeld3,
  9. G Schillaci1,
  10. E Mannarino1
  1. 1Internal Medicine, Angiology and Arteriosclerosis, University of Perugia School of Medicine, Perugia, Italy
  2. 2Internal Medicine and Oncological Sciences, University of Perugia School of Medicine, Perugia, Italy
  3. 3Department of Medicine B, and Centre for Autoimmune Diseases, Chaim Sheba Medical Centre, Tel-Hashomer, Israel
  1. Correspondence to:
    Dr G Vaudo
    Unit of Internal Medicine, Angiology and Arteriosclerosis, Department of Clinical and Experimental Medicine, University of Perugia School of Medicine, via Brunamonti, 51-06122 Perugia, Italy; gvaudounipg.it

Abstract

Background: Rheumatoid arthritis (RA) is associated with an increased risk of cardiovascular disease. Endothelial dysfunction represents the earliest stage of atherosclerosis.

Objective: To evaluate the influence of chronic inflammatory state on endothelial function in patients with RA by measuring endothelial reactivity in young patients with RA with low disease activity and without traditional cardiovascular risk factors.

Methods: Brachial flow mediated vasodilatation (FMV), assessed by non-invasive ultrasound, was evaluated in 32 young to middle aged patients with RA (age ⩽59 years), with DAS28 ⩽3.2 and without overt cardiovascular disease, and in 28 age and sex matched controls.

Results: Mean (SD) FMV was significantly lower in patients than in controls (3.2 (1.3)% v 5.7 (2.0)%; p<0.001), inversely related to low density lipoprotein cholesterol (r = −0.45, p<0.05) and C reactive protein (CRP), expressed as the value at the moment of ultrasound evaluation (r = −0.44, p<0.05), as the average of CRP levels evaluated at different times during the disease (r = −0.47, p<0.05), or as the average of ⩾4 determinations multiplied by the disease duration (r = −0.40, p<0.05). In a multivariate regression model, a lower brachial flow mediated vasodilatation was independently predicted by low density lipoprotein cholesterol (β = −0.40, p<0.05), average CRP levels multiplied by the disease duration (β = −0.44, p<0.05), and brachial artery diameter (β = −0.28, p<0.05).

Conclusions: Young to middle aged patients with RA with low disease activity, free from cardiovascular risk factors and overt cardiovascular disease, have an altered endothelial reactivity that seems to be primarily related to the disease associated chronic inflammatory condition.

  • rheumatoid arthritis
  • endothelial function
  • flow mediated vasodilatation
  • C reactive protein
  • CRP, C reactive protein
  • DAS, Disease Activity Score
  • FMV, flow mediated vasodilatation
  • HDL, high density lipoprotein
  • LDL, low density lipoprotein
  • RA, rheumatoid arthritis
  • RF, rheumatoid factor

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes